FDW028

CAS No. 2768426-49-7

FDW028( —— )

Catalog No. M37123 CAS No. 2768426-49-7

FDW028 is a selective and potent fucosyltransferase 8 (FUT8) inhibitor with anti-tumor activity that drives B7-H3 lysosomal degradation via defucosylation and CMA pathways. FUT8 can be used to study metastatic colorectal cancer (mCRC).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 97 Get Quote
5MG 145 Get Quote
10MG 235 Get Quote
25MG 476 Get Quote
50MG 762 Get Quote
100MG 1188 Get Quote
500MG 2385 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    FDW028
  • Note
    Research use only, not for human use.
  • Brief Description
    FDW028 is a selective and potent fucosyltransferase 8 (FUT8) inhibitor with anti-tumor activity that drives B7-H3 lysosomal degradation via defucosylation and CMA pathways. FUT8 can be used to study metastatic colorectal cancer (mCRC).
  • Description
    FDW028 a potent and highly selective FUT8 inhibitor. FUT8 exhibits potent anti-tumor activity by defucosylation and impelling lysosomal degradation of B7-H3 through the chaperone-mediated autophagy (CMA) pathway. FDW028 can be used for metastatic colorectal cancer (mCRC) research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Transferase
  • Recptor
    Transferase | Autophagy
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2768426-49-7
  • Formula Weight
    388.47
  • Molecular Formula
    C22H24N6O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (257.42 mM; Ultrasonic )
  • SMILES
    OC1=CC(=NC2=NC(=NN21)NCC3=CC=C(C=C3)CC)CNCC=4C=CC=CC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wang M, et al. FDW028, a novel FUT8 inhibitor, impels lysosomal proteolysis of B7-H3 via chaperone-mediated autophagy pathway and exhibits potent efficacy against metastatic colorectal cancer. Cell Death Dis. 2023 Aug 3;14(8):495.?
molnova catalog
related products
  • Entacapone

    Entacapone is a selective, reversible catechol-O-methyl transferase (COMT) inhibitor for the treatment of Parkinson's disease.

  • Minodronic acid mono...

    Minodronic acid monohydrate?is an farnesyl diphosphate synthase inhibitor that acts as a bone resorption inhibitor.

  • Eliglustat

    Eliglustat (Tartrate) inhibits?glucosylceramide synthase(GCS),thus reducing the load of glucosylceramide influx into the lysosome.